There has been a series of confusing studies over estrogen. Many menopausal women went off the drug when increased rates of breast cancer were found. However, recent findings are challenging this conventional wisdom as a “major government study has found that years after using estrogen-only therapy, certain women had a markedly reduced risk of breast cancer and heart attack,” according to The New York Times. The key, says Tara Parker-Pope, reporter for The New York Times, is that these women were only on estrogen, and not progestin. She explains the findings and what this means for women.
We rely on support from listeners and readers like you to keep our stories free and accessible to all. Monthly gifts are particularly meaningful because they help us plan ahead and concentrate on the stories that matter. Will you consider donating $10/month, so we can continue bringing you The World? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!